Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Healthcare Realty Trust (HR)

Healthcare Realty Q4 NAREIT FFO rises to $0.36 per share; 2026 outlook issued

Positive Impact 3 of 5 earnings Written later

Healthcare Realty reported fourth quarter 2025 GAAP net income of $14.4 million, or $0.04 per share, compared with a net loss of $106.8 million a year earlier, and NAREIT FFO rose to $0.36 per share from $0.30. The company also issued 2026 guidance calling for Normalized FFO of $1.58 to $1.64 per share, roughly flat with $1.61 in 2025, and a $0.24 quarterly dividend.

Key points

  • Q4 2025 GAAP net income was $14.4 million ($0.04 per share) versus a net loss of $106.8 million ($0.31 per share) in Q4 2024.
  • Q4 2025 NAREIT FFO was $0.36 per share versus $0.30; Normalized FFO was $0.40 per share, unchanged from the prior year.
  • 2026 guidance: Normalized FFO of $1.58 to $1.64 per share (2025: $1.61) and NAREIT FFO of $1.44 to $1.50 (2025: $1.38).
  • Dividend of $0.24 per share payable March 11, 2026, to holders of record on February 24, 2026; new commercial paper program of up to $600 million.

The filing

CompanyHealthcare Realty Trust (HR)
Form8-K, current report
Filed with the SECFeb 12, 2026, 4:17 PM ET
Accession number0001360604-26-000015

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 12, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.